New AAD Atopic Dermatitis Guidelines and Dupilumab Label Updates
Five experts delved into the latest updates to treatment guidelines and the updated label use for dupilumab for hand-foot AD.
Five experts delved into the latest updates to treatment guidelines and the updated label use for dupilumab for hand-foot AD.
Occurring every May, Skin Cancer Awareness Month is devoted to shining the spotlight on the most common cancer in the United States — skin cancer.
Thursday, June 20, 2024 9:40 – 10:40 AM CT CME/CNE Virtual Join us for a symposium on major depressive disorder (MDD) designed to encourage the…
Keep up with the latest headlines in dermatology from the past week, including Johnson & Johnson’s acquisition of Proteologix, a review of sunscreen approvals and…
Supported by an independent educational grant from Edwards Lifesciences. During this live webinar, an expert faculty will review the prevalence and burden of tricuspid regurgitation…
Supported by an independent educational grant from Lilly. What to do when a patient shows possible signs and symptoms of Alzheimer’s disease? This webinar, the…
In case you missed it, this week we had news about roflumilast foam’s efficacy in diverse hair types of seborrheic dermatitis, Lindus Health’s new partnership…
Unless you have been under a pile of retention hyperkeratosis, it would be hard to say one has not heard the call to purposefully diversify…
How much do you know about gastroesophageal reflux disease (GERD) and its diagnosis and treatment? In this engaging, interactive symposium, participants will get to test…
Scassellati Sforzolini discusses the significance of Galderma’s nemolizumab receiving 4 additional filing acceptances for prurigo nodularis and atopic dermatitis.
Cre ate a non-member account if you are applying for membership or need to interact with AAD systems. Non-member accounts do not have access to…